In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it.
- view as grid
- view as list
In his latest column for The Wall Street Journal‘s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it. All previous columns by Drew Altman are online.
The ACA’s third open enrollment will come to a close at the end of January and the December Kaiser Health Tracking Poll finds that only 7 percent of the uninsured correctly identify this as the deadline to enroll in coverage. With Democratic presidential candidates debating the idea of Medicare-for-all, which involves creating a national health plan in which all Americans would get their insurance through an expanded version of the Medicare program, most Democrats like the idea, but very few say the issue will drive their votes in the 2016 elections. As the U.S. Senate voted to repeal the Affordable Care Act (ACA) earlier this month, more of the public views the health care law unfavorably than favorably (46 percent vs. 40 percent). In addition, the public remains divided over what Congress should do next with the law, with 35 percent supporting repeal, 14 percent supporting scaling back the law, 18 percent who say they would like to see it implemented as is, and 22 percent who say they want the law expanded.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses surprise bills for out-of-network care, and New York state’s solution to the problem. All previous columns by Drew Altman are online.
This is an abbreviated topline for the upcoming January 2016 Kaiser Health Tracking Poll. It contains the survey questions addressed in Drew Altman’s column, “Candidate Policy Plans Resonate More With Democrats. Here’s Why,” for The Wall Street Journal’s Think Tank.
Large Majorities Favor Wide Range of Policy Changes to Curb Prescription Drug Costs, Including Those That Give Government a Greater Role in Negotiating or Limiting Prices
Amid news reports about increases in the price for EpiPen and other drugs, the vast majority of Americans – including majorities of Democrats, Republicans and independents – support several policy changes to control the cost of prescription drugs, including some that would expand government’s role in drug pricing, the latest…
This month’s Kaiser Health Tracking Poll examines top issues to voters in the presidential election and finds that while health care ranks low, voters report being aware of the differences between Clinton’s and Trump’s health care proposals. Findings also include a look at which health care issues the next president and Congress should prioritize, the future of the Affordable Care Act, as well as Americans’ views on the creation of a public health insurance option.
New Analysis Finds Out-of-Pocket Prescription Drug Spending Decreasing on Average, But More People Spending in Excess of $1,000 a Year
A new Kaiser Family Foundation analysis finds that average annual out-of-pocket prescription drug spending for workers and family members decreased from a recent high of $167 in 2009 to $144 in 2014. Most of the decline in out-of-pocket spending occurred between 2009 and 2012 and is likely due to generic…
Where does President-elect Donald Trump stand on key health care issues? This snapshot outlines his positions and policy statements during the campaign on issues such as health insurance, the ACA, Medicaid, Medicare, the opioid epidemic, prescription drug costs, and women’s reproductive health.